Cooperation between action medeorBayerBoehringer Ingelheim and Merck enters second phase

To better protect patients from undesirable side effects of medicines, pharmacists will be more closely involved in Tanzanian clinics. This is the goal of a multi-stakeholder partnership (MSP) launched by action medeorBayerBoehringer Ingelheim and Merck, which is now entering its second phase. In the first phase, a roundtable was initiated in 2017 for uniform and comprehensive training of pharmaceutical assistants and technicians, to ensure the care of patients in rural areas of Tanzania.

The press release of action medeor (in german) can be found here.

This might also interest you:

p2023 news thumbnail
News
Partnership for Sustainable Textiles celebrates its 10th anniversary: achievements and future prospects 
p2023 news thumbnail
News
With Partnerships2030 towards the Future
p2023 news thumbnail
News
Together for sustainable climate protection solutions: multi-stakeholder partnerships for global climate goals